View by Specialty

Headline News

View more

VIDEO: Axpaxli for wet AMD shows durability, safety in phase 1 trial

May 21, 2024
2 min watch
Save

VIDEO: Axpaxli for wet AMD shows durability, safety in phase 1 trial

VIDEO: Axpaxli for wet AMD shows durability, safety in phase 1 trial

FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Dilsher S. Dhoot, MD, discusses 52-week phase 1 data for Axpaxli for the treatment of neovascular age-related macular degeneration.

View more Headline News
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails

Resources

View more
View more Resources
View more Meeting News

Upcoming Meetings

Blogs & Columns

View more
A closer look at drug discoveries and developments that affect clinical practice.
Philip A. Bain, MD FACP

Clinical Pearls for the Frontline PCP

with Philip A. Bain, MD, FACP
Practical advice and clinical workflows on medical conditions that are frequently seen in primary care.
View more Blogs & Columns